The therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study
Authors:
Open Access
- 26 June 2023
- journal article
- review article
- Published by Elsevier in Sleep Medicine
- Vol. 109, 118-127
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Orexin/hypocretin role in reward: implications for opioid and other addictionsBritish Journal of Pharmacology, 2014
- Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphineNeuropeptides, 2014
- Reward-based behaviors and emotional processing in human with narcolepsy-cataplexyFrontiers in Behavioral Neuroscience, 2013
- Molecular Mechanisms of Opioid Receptor-dependent Signaling and BehaviorAnesthesiology, 2011
- A Multi‐Drug Intoxication Fatality Involving Xyrem® (GHB)Journal of Forensic Sciences, 2009
- μ-Opioid Receptor-Mediated Depression of the Hypothalamic Hypocretin/Orexin Arousal SystemThe Journal of Neuroscience, 2008
- Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawalJournal of Endocrinology, 2006
- Narcolepsy and cardiac surgery: can anesthesia with propofoland remifentanil be safe?Journal of Cardiothoracic and Vascular Anesthesia, 2004
- Intricate Regulation of Tyrosine Hydroxylase Activity and Gene ExpressionJournal of Neurochemistry, 1996
- GELINEAU'S NARCOLEPSY RELIEVED BY OPIATESThe Lancet, 1981